Rybelsus in combination with standard T2DM therapy reduced the risk of major cardiovascular events by 14% in patients with ...

The management of bone and joint infections has long relied on intravenous (IV) antibiotics. Still, emerging evidence ...

Discover key genes linked to early diabetes in South Asians, highlighting unique genetic factors contributing to higher ...

Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation GKA candidate in U.S. at the 9th China ...

In a clinical practice guideline issued by the American Academy of Sleep Medicine and published online Sept. 26 in the ...

SHANGHAI, Nov 30, 2024 - (ACN Newswire) - Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which ...

With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative ...

In fact, as many as 35% of people with IBD have some kind of oral manifestation of the condition, such as canker sores, the ...

GLP-1R injectable drugs are effective in treating obesity, but their success points to a gap in the market: oral alternatives ...

Hot flashes and night sweats are among the most infamous menopause maladies. But you might want to pay attention to your ...

Mouthwash is a common part of many people’s daily routines, known for keeping our mouths clean, reducing harmful bacteria, ...

Telomir Pharmaceuticals, Inc. ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced groundbreaking preclinical results confirming the efficacy of its licensed ...